An observational study in Gastrointestinal Stromal Tumors, sponsored by Cirujanos la Serena. Completed at 1 site in Chile. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2011-08-11.
Sponsored by Cirujanos la Serena · Observational
This is a retrospective analysis and description of the preferred diagnostic and treatment methods employed on GIST on the Region of Coquimbo from 2003 to 2008.
333 studies on the registry are indexed under Gastrointestinal Stromal Tumors; 61 are open to participants now.
This study's enrollment of 24 is below the median of 116 across 68 observational studies indexed under Gastrointestinal Stromal Tumors.
Browse Gastrointestinal Stromal Tumors studies →Cirujanos la Serena is the lead sponsor of 10 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients operated on for GIST
Exclusion Criteria:
GIST from all gastrointestinal origins: esophagus, stomach, duodenum, jejunum, ileum, colon and rectum
Other: Observation
Not applied
Number of Patients Who Survived
The outcomes were measured through follow-up visits of the patients to the out-patient clinic of our institution at 15 days, 1 month, 3 months, 6 months, 1 year, and after that, every year after the surgical treatment.
Time frame: 5 years
Hospital patients operated on for Gastrointestinal stromal tumor (GIST)
| Milestone | Gastrointestinal Stromal Tumor (GIST) |
|---|---|
| Started | 24 |
| Completed | 24 |
| Not completed | 0 |
The outcomes were measured through follow-up visits of the patients to the out-patient clinic of our institution at 15 days, 1 month, 3 months, 6 months, 1 year, and after that, every year after the surgical treatment.
| Participants | Gastrointestinal Stromal Tumor (GIST) |
|---|---|
| Number of Patients Who Survived | 5 |
Collected over No adverse events were assessed or collected (0/24). Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Gastrointestinal Stromal Tumor (GIST) | — | — | — |
| Age, Categorical(Participants) | Gastrointestinal Stromal Tumor (GIST) |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 22 |
| >=65 years | 2 |
| Age Continuous(years) | Gastrointestinal Stromal Tumor (GIST) |
|---|---|
| Mean | 49 ± 15.4 |
| Sex: Female, Male(Participants) | Gastrointestinal Stromal Tumor (GIST) |
|---|---|
| Female | 12 |
| Male | 12 |
| Region of Enrollment(participants) | Gastrointestinal Stromal Tumor (GIST) |
|---|---|
| Chile | 24 |
This study is completed, as verified in Sep 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gastrointestinal Stromal Tumors→
Cirujanos la Serena